Pharmaceuticals, Biotechnology and Life Sciences
Succeeds current Chief Executive Officer and co-founder Onno van de Stolpe, following planned retirementRecognized as inspirational industry leader with exceptional…
Early data in the combination study of CUE-101 and KEYTRUDA® (pembrolizumab) supports synergistic activity; of four patients treated in dose…
Issuance of 3rd tranche of €500,000 of notes convertibles into new shares DEINOVE strengthens its cash position to finance its…
City of Vacaville and Polaris Pharmaceuticals Vacaville Mayor Ron Rowlett (right) meets with Vacaville’s Polaris Pharmaceuticals Principal Engineer Mary Scomona,…
BUFFALO, N.Y., Jan. 26, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused…
Natrunix-SQ, A True Human Antibody Therapy Discovered and Manufactured at XBiotech, Is Aimed as a Breakthrough Treatment for Arthritic DiseaseAUSTIN,…
TORONTO, Jan. 26, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0, OTC Pink: CMNDF) (“Clearmind” or the…
MINNEAPOLIS, Jan. 26, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for…
BERKELEY, Calif. and MAINZ, Germany, Jan. 26, 2022 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),…
BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Jan. 25, 2022 (GLOBE NEWSWIRE) — Roivant Sciences (Nasdaq: ROIV) today…